✦ LIBER ✦

Laboratory variables and stratification of metastatic colorectal cancer patients: recommendations for therapeutic trials and for clinical practice guidelines

✍ Scribed by Joseph Watine; Bruno Friedberg

Book ID: 116349818
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 178 KB
Volume: 345
Category: Article
ISSN: 0009-8981
DOI: 10.1016/j.cccn.2004.02.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical practice guidelines for breast

Clinical practice guidelines for breast cancer rehabilitation : Syntheses of guideline recommendations and qualitative appraisals

✍ Susan R. Harris; Kathryn H. Schmitz; Kristin L. Campbell; Margaret L. McNeely 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 824 KB

P15-05. Evaluation and recommendations o

P15-05. Evaluation and recommendations on good clinical laboratory practice (GCLP) guidelines for phase I-III HIV vaccine clinical trials

✍ M Sarzotti-Kelsoe, J Cox, N Cleland, T Denny, J Hural, L Needham, D Ozaki… 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 64 KB

All about KRAS for clinical oncology pra

All about KRAS for clinical oncology practice: Gene profile, clinical implications and laboratory recommendations for somatic mutational testing in colorectal cancer

✍ Helena Linardou; Evangelos Briasoulis; Issa J. Dahabreh; Giannis Mountzios; Chri 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 842 KB

Designing Therapeutic Clinical Trials fo

Designing Therapeutic Clinical Trials for Older and Frail Adults With Cancer: U13 Conference Recommendations

✍ Hurria, A.; Dale, W.; Mooney, M.; Rowland, J. H.; Ballman, K. V.; Cohen, H. J.; 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 126 KB

Survival Outcomes for Patients with Meta

Survival Outcomes for Patients with Metastatic Triple-Negative Breast Cancer: Implications for Clinical Practice and Trial Design

✍ Farrah Kassam; Katherine Enright; Rebecca Dent; George Dranitsaris; Jeff Myers; 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 117 KB

Phase II Trial of Erlotinib and Capecita

Phase II Trial of Erlotinib and Capecitabine for Patients with Previously Untreated Metastatic Colorectal Cancer

✍ Peter Kozuch; Steve Malamud; Carrie Wasserman; Peter Homel; Takhir Mirzoyev; Mic 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 108 KB